Fate Therapeutics, Inc. (FATE)

1.485 -0.08 (-4.81%) USD  |  NASDAQ  |  Feb 27, 16:00
1.485 0.00 (0.00%) After-Hours: 18:00
More

Fate Therapeutics Other Operating Expenses (Quarterly)

Other Operating Expenses (Quarterly) Chart

View Other Operating Expenses (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Operating Expenses (Quarterly) Range, Past 5 Years

View Other Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Operating Expenses (Quarterly) Benchmarks

View Other Operating Expenses (Quarterly) Benchmarks
Start Trial
MannKind Corp. --
Vertex Pharmaceuticals, Inc. --
Ardelyx, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --